4th Annual Pharmacovigilance Asia 2013

18 - 21 June, 2013

Amara Hotel, Singapore

Download the Agenda

Singapore Companies: Get 60% Cashback

The Productivity Innovation Credit (PIC) Scheme saves your organization 60% of the registration. Simply complete the 10 minute application and save over $1,000. For more information, visit: www.iqpc.sg/PIC


The IQPC Pharmacovigilance conference in Singapore, which is becoming an annual event is, to my knowledge, the most comprehensive information exchange and discussion forum dedicated to pharmacovigilance held in Asia so far! - Head of Pharmacovigilance Asia-Pacific, Bayer Healthcare Global R&D Centre
Had an overall understanding of pharmacovigilance running in Asia, particularly in ASEAN. It is helpful for me to make a plan locally and accelerate a pharmacovigilance strategy locally. - Director of Regulatory Affairs, Nycomed China
The topics discussed in this conference are simple enough for a beginner and complex enough for the experienced. Brilliant! - Senior Safety Officer, GSK
Very valuable conference & excellent sharing of pharmacovigilance experiences and best practices – Country Safety Head, Pfizer
Very well organised conference! Attendee mix was nice – including industry and regulators! Well done! - Head, Lifesciences EU & APAC, Cognizant
This conference offers the opportunity for those working in pharmacovigilance to share expertise and learn about best practices and challenge the way they do things. - Pharmacovigilance manager, MSD
Good discussions and good comments from all representatives and speakers! - CPM, EPS International

Sponsors & Exhibitors
TAKE Solutions
Media Partners

Stay Connected


Become a Pharma IQ Member and receive our weekly newsletter!

2013 Expert Speakers

 Kelly Teo
Kelly Teo
Regional Pharmacovigilance Lead, Asia Pacific
Dr. Abhay Chimankar
Dr. Abhay Chimankar
Global Safety Officer
 Shinichi Nishiuma
Shinichi Nishiuma
Vice President, Japanese Association of Pharmaceutical Medicine, Senior Medical Advisor, Senior Manager, Surveillance and Epidemiology, Global Dr Efraim Ariesandy Patient Safety
Eli Lilly Japan

Updates from Regulatory Bodies Including:

  • Dr.Wenmin Du, Executive Director, Shanghai Centre for Adverse Drug Reaction Monitoring, SFDA
  • Dr Y K Gupta, National Scientific Coordinator, Pharmacovigilance program of India
  • Dra. A. RetnoTyasUtami, Apt.M. Epid, Deputy Director, Therapeutic Products, Narcotic, Psychotropic and Addictive Substances, BPOM Indonesia
  • Mohamad Khalid Haji Zolkipli, National Adverse Drug Reaction Monitoring Centre, Department of Pharmaceutical Services, Ministry of Health Brunei Darussalam
  • Senior Representative, Korea FDA

Other Regulatory Bodies Attending:

  • Health Sciences Authority Singapore
  • FDA, Thailand
  • National Pharmaceutical Control Bureau Malaysia
  • Food & Drug Development, Lao PDR
  • National Centre for Drug Information and ADR Reporting, Vietnam

Learn practical tips to implement risk management, audit, inspection and adverse drug reaction management strategies whilst complying to regulatory requirements

“Make pharmacovigilance a key topic of the next ICDRA … reinforce recommendations that the pharmacovigilance system be nested within the healthcare system to address multiple growing safety needs.”

-World Health Organization (WHO)

Can’t afford to fail a pharmacovigilance audit or inspection?

Feel like you need more advice on risk management planning or how various pharmacovigilance regulations in Asia will impact you on a daily basis?

Then join us at Asia’s leading event for pharmacovigilance in Asia, together with Heads of Pharmacovigilance, Directors of Drug Safety, Medical Affairs Officers, Medical Safety Managers from pharmas, country FDAs and more!

» Download the brochure now

Join Us Now And Benefit By Learning From:

  • 13 industry best practice case studies to empower you with proven successful strategies on risk management planning, ADR reporting and monitoring, regulatory compliance, audit and inspection preparation
  • Best practice case studies on developing effective risk management plans and PSURs pre and post marketing
  • Industry secrets that will help you best prepare for a pharmacovigilance audit and inspection

» Register now

Key Conference Highlights:

  • Our panel and roundtable discussions as well as speed networking sessions that are distributed across the 2 days conference will guarantee you will get personal access to regulatory bodies representatives throughout your stay at the event. No more of regulators leaving right after their presentation!
  • Regulator-led Roundtable Discussion - Attend one of the 4 regulator-led groups based on your region focus: Southeast Asia, Greater China, India and Northeast Asia
  • 4 in-depth workshops facilitated by industry leaders to provide solutions for your key challenges

» Find out who’s attending